Twist Bioscience

Yahoo Finance • 2 days ago

Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposure

Joe Raedle Cathie Wood’s ARK Invest funds executed a broad rotation across technology, healthcare, and industrial names during the last week while markets remained volatile over broader geopolitical tensions between the U.S. and Iran. Bu... Full story

Yahoo Finance • 11 days ago

Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

Cathie Wood’s ARK Invest funds have delivered mixed performance in the recent period, with ARK Space & Defense Innovation ETF (ARKX [https://seekingalpha.com/symbol/ARKX]) up 1.27% and ARK Autonomous Technology & Robotics ETF (ARKQ [https:... Full story

Yahoo Finance • 2 months ago

Twist Bioscience falls after over $2M insider sale

[Red dollar sign pointing down with arrow, concept of financial loss, market decline and recession, 3d render] * Twist Bioscience (TWST [https://seekingalpha.com/symbol/TWST]) lost ~7% in the premarket on Friday after its Senior Vice Pr... Full story

Yahoo Finance • 2 months ago

Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification

Twist Bioscience logo Key Points All three director nominees—Keith Crandell, Jan Johannessen and Trynka Shineman Blake—were duly elected; the non‑binding advisory vote approving executive compensation was approved, and stockholders ratif... Full story

Yahoo Finance • 2 months ago

Cathie Wood buys $43 million of megacap tech stock

It’s been a rocky start to the year for Cathie Wood, the head of Ark Investment Management. As of Feb. 6, Wood’s flagship Ark Innovation ETF (ARKK) was down 9.58% year to date, while the S&P 500 gained 1.27%, as pressure mounted on growth... Full story

Yahoo Finance • 2 months ago

Twist Bioscience Q1 Earnings Call Highlights

Twist Bioscience logo Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 first-quarter results that management said extended a multi-year trend of consistent execution, highlighting its 12th consecutive quarter of revenue growth and cont... Full story

Yahoo Finance • 2 months ago

Twist Bioscience outlines $435M–$440M 2026 revenue target while accelerating AI-enabled discovery investments

Earnings Call Insights: Twist Bioscience (TWST) Q1 2026 MANAGEMENT VIEW * CEO Emily Leproust highlighted "a strong start to fiscal 2026 and extend a pattern of consistent execution, marking our 12th consecutive quarter of revenue growt... Full story

Yahoo Finance • 2 months ago

Twist Bioscience Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Monday, February 2, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Co-Founder — Dr. Emily Leproust President and Chief Operating Officer — Dr. Patrick Finn Chief Financial Officer —... Full story

Yahoo Finance • 3 months ago

Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)

Twist Bioscience Corporation (NASDAQ:TWST) is among the 12 Best Genomics Stocks to Invest In.Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) TheFly reported on December 15, 2025, that Barclays kept its Overweig... Full story

Yahoo Finance • 3 months ago

TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock

This article first appeared on GuruFocus. Cathie Wood's Ark Invest increased stakes in gene-editing and autonomous mobility companies while trimming holdings in Tesla (NASDAQ:TSLA) and Rocket Lab (NASDAQ:RKLB). Selling activity focused o... Full story

Yahoo Finance • 4 months ago

Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock

[Bitcoin 2022 Conference Draws Cryptocurrency Industry Professionals And Investors To Miami] Marco Bello Cathie Wood’s Ark Invest increased exposure to gene-editing names and autonomous mobility companies while further cutting holdings in... Full story

Yahoo Finance • 4 months ago

Noteworthy ETF Outflows: ARKG, TEM, TWST, GH

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ARK Genomic Revolution ETF (Symbol: ARKG) where we have detected an approximate $73.5 million dollar outflow... Full story

Yahoo Finance • 4 months ago

Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., December 18, 2025--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience... Full story

Yahoo Finance • 4 months ago

Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to sha... Full story

Yahoo Finance • 5 months ago

Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT

Twist Bioscience Corporation (NASDAQ:TWST) is one of the best gene-editing stocks to buy according to hedge funds. On November 4, Steven Etoch, an analyst at Stephens, began coverage of Twist Bioscience Corporation (NASDAQ:TWST). Etoch ass... Full story

Yahoo Finance • 5 months ago

Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity?

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities continue to rally in the third quarter, the period w... Full story

Yahoo Finance • 5 months ago

Twist Bioscience outlines 13–15.5% revenue growth target for 2026 as AI-driven orders accelerate

Earnings Call Insights: Twist Bioscience Corporation (TWST) Q4 2025 MANAGEMENT VIEW * CEO Emily Leproust highlighted a record quarter with $99 million in revenue and 17% year-over-year growth, noting "our 11th quarter of consecutive gr... Full story

Yahoo Finance • 5 months ago

Twist Bioscience GAAP EPS of -$0.45 misses by $0.03, revenue of $99M beats by $1.64M

* Twist Bioscience press release [https://seekingalpha.com/pr/20307952-twist-bioscience-announces-fiscal-2025-fourth-quarter-and-full-year-financial-results] (TWST [https://seekingalpha.com/symbol/TWST]): Q4 GAAP EPS of -$0.45 misses by... Full story

Yahoo Finance • 5 months ago

Cathie Wood doubles down on Alibaba: ARK Invest snaps up $25M in Chinese tech stocks

This article first appeared on GuruFocus. ARK Invest funds boosted holdings in Alibaba (NYSE:BABA) and Baidu (NASDAQ:BIDU) while trimming stakes in Reddit (RDDT), Exact Sciences (EXAS) and Iridium Communications (IRDM), according to Wedne... Full story

Yahoo Finance • 5 months ago

Twist Bioscience (TWST): Exploring Valuation Following Fresh Analyst Coverage and Product Launch Collaboration

Twist Bioscience (TWST) saw fresh attention after Stephens launched analyst coverage, highlighting the company’s innovative DNA synthesis technology and recent moves. These moves include a new sequencing workflow with Element Biosciences a... Full story